Abstract
Aim: In this paper, we provide an update on the conceptual issues of psychiatric neuroimaging, especially in the light of the current reductive claims of the eliminative physicalism.
Argument: our argument is developed on three stages. The first is to highlight the crucial importance of phenomenological psychopathology and person-centered approach, which remains underestimated; the second is to bring forward the view that functional neuroimaging is relevant to the area of ‘translation’ in the mind-brain debate. The third point is to present a critical analysis of the shortcomings in structural and functional neuroimaging from methodological and epistemological perspectives.
Conclusion: a novel paradigm for translational cross-validation among neuroscience, psychopathology and clinical psychology is presented.
Keywords: Functional neuroimaging, translation, validity, methodology
Current Topics in Medicinal Chemistry
Title:Conceptual Issues in Psychiatric Neuroimaging: An Update
Volume: 12 Issue: 21
Author(s): D. Stoyanov, G. Stanghellini and M. Broome
Affiliation:
Keywords: Functional neuroimaging, translation, validity, methodology
Abstract: Aim: In this paper, we provide an update on the conceptual issues of psychiatric neuroimaging, especially in the light of the current reductive claims of the eliminative physicalism.
Argument: our argument is developed on three stages. The first is to highlight the crucial importance of phenomenological psychopathology and person-centered approach, which remains underestimated; the second is to bring forward the view that functional neuroimaging is relevant to the area of ‘translation’ in the mind-brain debate. The third point is to present a critical analysis of the shortcomings in structural and functional neuroimaging from methodological and epistemological perspectives.
Conclusion: a novel paradigm for translational cross-validation among neuroscience, psychopathology and clinical psychology is presented.
Export Options
About this article
Cite this article as:
Stoyanov D., Stanghellini G. and Broome M., Conceptual Issues in Psychiatric Neuroimaging: An Update, Current Topics in Medicinal Chemistry 2012; 12 (21) . https://dx.doi.org/10.2174/1568026611212210007
DOI https://dx.doi.org/10.2174/1568026611212210007 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of Estrogen and Estrogen-Related Drugs in Cardiovascular Diseases
Current Drug Metabolism High Sensitivity Troponin in Cardiovascular Disease. Is There More Than a Marker of Myocardial Death?
Current Topics in Medicinal Chemistry Glucose Metabolism and Insulin Resistance in Sepsis
Current Pharmaceutical Design Host Microbe Interactions: A Licence to Interfere?
Current Pharmaceutical Biotechnology Molecular Targets of Diabetic Cardiovascular Complications
Current Drug Targets A synopsis on the linkage between age-related dementias and vascular disorders
CNS & Neurological Disorders - Drug Targets Editorial [Hot Topic: Therapeutic Angiogenesis and Regeneration in Cardiovascular Diseases (Executive Editor: Masafumi Takahashi)]
Current Pharmaceutical Design Therapeutic Strategies for Treatment of Inflammation-related Depression
Current Neuropharmacology Protective Effect of Zinc on Mouse Renal Ischemia-reperfusion Injury by Anti-apoptosis and Antioxidation
Current Pharmaceutical Biotechnology Lower Financial Status and Adherence to Medication Determines 10-Year (2004-2014) All-Cause Mortality and Risk for Acute Coronary Syndrome Incidence Among Cardiac Patients: the GREECS Study
Current Vascular Pharmacology Smoking and Cardiovascular System: Cellular Features of the Damage
Current Pharmaceutical Design C-Reactive Protein and Asymmetric Dimethylarginine: Markers or Mediators in Cardiovascular Disorders?
Current Pharmaceutical Design Relationship between Augmentation Index and Wall Thickening Fraction during Hypotension in an Animal Model of Myocardial Ischemia-Reperfusion and Heart Failure
Current Hypertension Reviews The Cardiovascular Effects of Metformin: Further Reasons to Consider An Old Drug as a Cornerstone in the Therapy of Type 2 Diabetes Mellitus
Current Vascular Pharmacology Mitochondrial Uncoupler Proteins
Current Enzyme Inhibition Regulation of Oxidative Stress and Cardioprotection in Diabetes Mellitus
Current Cardiology Reviews Type 2 Transglutaminase in Neurodegenerative Diseases: The Mitochondrial Connection
Current Pharmaceutical Design Cardiovascular Manifestations of COVID-19
Current Cardiology Reviews Interindividual Variability in the Efficacy of Oral Antiplatelet Drugs: Definitions, Mechanisms and Clinical Importance
Current Pharmaceutical Design Vasoactive Factors and Diabetic Retinopathy: Vascular Endothelial Growth Factor, Cycoloxygenase-2 and Nitric Oxide
Current Pharmaceutical Design